McKesson begins distribution of Johnson & Johnson's COVID-19 vaccine

March 1, 2021 6:39 AM EST

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

(Reuters) - U.S. drug distributor McKesson Corp said on Monday it had begun distribution of Johnson & Johnson's COVID-19 vaccine.

The vaccine became the third authorized COVID-19 vaccine in the United States over the weekend, following Friday's unanimous endorsement by the Food and Drug Administration's panel of outside experts.

McKesson is the partner for the U.S. government's COVID-19 vaccine distribution and the company has established four distribution centers which will be specifically used to distribute the Johnson & Johnson COVID-19 vaccine.

The U.S. government makes the administration decisions, including where, when and how many vaccine doses McKesson will distribute, the company said.

Initial deliveries of the vaccine should begin on Tuesday, senior Biden administration officials had said on Sunday.

(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

General News, Reuters

Related Entities